Valneva Reports Best FY Results in the Company´s History with its First Year of Positive EBITDA in 2016
(WorldNews France)

Valneva Reports Best Financial Results in the Company`s History with its First Year of Positive EBITDA in 2016 The Company expects to continue showing a strong financial performance in 2017 Total revenues and grants of EUR97.9 million in 2016 (vs EUR83.3 million in 2015) driven mainly by a 73.1% increase in IXIARO®/JESPECT®revenues; Valneva reported a positive EBITDA of EUR2.8 million in 2016 (vs. an EBITDA loss of EUR8.5 million in 2015); Net loss of EUR49.2 million in 2016, impacted by the impairment charges related to the Pseudomonas program termination. Excluding these charges and the exceptional gain related to the DUKORAL®acquisition in 2015, net loss was cut by more than half compared to 2015...